State of Wisconsin Investment Board increased its holdings in shares of Monsanto Company (NYSE:MON) by 28.9% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 788,898 shares of the basic materials company’s stock after purchasing an additional 176,648 shares during the quarter. State of Wisconsin Investment Board owned approximately 0.18% of Monsanto worth $94,526,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also made changes to their positions in the company. Pinnacle Financial Partners Inc. bought a new stake in Monsanto during the second quarter worth $114,000. Bruderman Asset Management LLC bought a new stake in Monsanto during the second quarter worth $116,000. Tower Research Capital LLC TRC raised its position in Monsanto by 230.1% during the second quarter. Tower Research Capital LLC TRC now owns 1,076 shares of the basic materials company’s stock worth $128,000 after acquiring an additional 750 shares in the last quarter. Armbruster Capital Management Inc. raised its position in Monsanto by 12.2% during the second quarter. Armbruster Capital Management Inc. now owns 1,147 shares of the basic materials company’s stock worth $136,000 after acquiring an additional 125 shares in the last quarter. Finally, Enterprise Financial Services Corp raised its position in Monsanto by 1.2% during the second quarter. Enterprise Financial Services Corp now owns 1,384 shares of the basic materials company’s stock worth $164,000 after acquiring an additional 16 shares in the last quarter. Institutional investors and hedge funds own 74.41% of the company’s stock.
Shares of Monsanto Company (NYSE:MON) traded down $0.08 during trading on Monday, reaching $119.79. 353,721 shares of the company’s stock were exchanged, compared to its average volume of 2,415,897. The firm has a market capitalization of $52,766.78, a P/E ratio of 21.68, a price-to-earnings-growth ratio of 1.72 and a beta of 1.05. The company has a debt-to-equity ratio of 1.12, a current ratio of 1.35 and a quick ratio of 0.83. Monsanto Company has a 12-month low of $97.35 and a 12-month high of $122.79.
Monsanto (NYSE:MON) last announced its quarterly earnings data on Wednesday, October 4th. The basic materials company reported $0.20 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.41) by $0.61. Monsanto had a net margin of 15.44% and a return on equity of 42.40%. The firm had revenue of $2.69 billion for the quarter, compared to the consensus estimate of $2.51 billion. During the same period in the prior year, the company posted $0.07 earnings per share. The business’s revenue for the quarter was up 4.8% on a year-over-year basis. research analysts forecast that Monsanto Company will post 5.74 earnings per share for the current year.
The business also recently declared a quarterly dividend, which was paid on Friday, October 27th. Stockholders of record on Friday, October 6th were paid a $0.54 dividend. The ex-dividend date was Thursday, October 5th. This represents a $2.16 dividend on an annualized basis and a dividend yield of 1.80%. Monsanto’s payout ratio is currently 42.27%.
TRADEMARK VIOLATION WARNING: “State of Wisconsin Investment Board Acquires 176,648 Shares of Monsanto Company (MON)” was first reported by Community Financial News and is owned by of Community Financial News. If you are reading this piece of content on another website, it was illegally copied and reposted in violation of U.S. & international copyright legislation. The original version of this piece of content can be accessed at https://www.com-unik.info/2017/11/06/state-of-wisconsin-investment-board-acquires-176648-shares-of-monsanto-company-mon.html.
Several analysts have issued reports on the stock. BMO Capital Markets reaffirmed a “buy” rating and set a $128.00 price target on shares of Monsanto in a research report on Thursday, October 5th. Barclays PLC reaffirmed an “equal weight” rating and set a $124.00 price target (up from $120.00) on shares of Monsanto in a research report on Thursday, October 5th. Macquarie lowered shares of Monsanto from an “outperform” rating to a “neutral” rating in a research report on Wednesday, October 4th. Wells Fargo & Company increased their price objective on shares of Monsanto from $107.50 to $118.00 and gave the company a “market perform” rating in a research report on Tuesday, October 10th. Finally, Jefferies Group LLC reissued a “hold” rating and issued a $128.00 price objective on shares of Monsanto in a research report on Friday, September 15th. Eleven analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $124.61.
In other news, EVP Steven Mizell sold 11,526 shares of the firm’s stock in a transaction that occurred on Monday, October 9th. The shares were sold at an average price of $119.70, for a total value of $1,379,662.20. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, COO Brett D. Begemann sold 22,640 shares of the firm’s stock in a transaction that occurred on Monday, September 25th. The shares were sold at an average price of $120.03, for a total transaction of $2,717,479.20. Following the completion of the sale, the chief operating officer now owns 85,439 shares in the company, valued at $10,255,243.17. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 49,236 shares of company stock worth $5,931,934. 0.79% of the stock is currently owned by corporate insiders.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
What are top analysts saying about Monsanto Company? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Monsanto Company and related companies.